Special Warning : אזהרת שימוש

4.4   Special warnings and precautions for use
Peritonitis, gastric and hepatic disorders and gastrointestinal surgery 
Patients with a recent history of peritonitis (within the last 3 months), significant gastric or hepatic disorders and patients with major gastrointestinal surgery have not been included in clinical studies with Velphoro. Velphoro treatment should only be used in these patients following careful assessment of benefit/risk.

Discoloured stool

Sucroferric oxyhydroxide can cause discoloured (black) stool. Discoloured (black) stool may visually mask gastrointestinal bleeding (see section 4.5).


Information about sucrose and starches (carbohydrates)
Velphoro contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicinal product. It may be harmful to the teeth.

Velphoro contains potato starch and pregelatinised maize starche. Patients with diabetes should take notice that one tablet of Velphoro is equivalent to approximately 1.4 g of carbohydrates (equivalent to 0.116 bread units).

Effects on Driving

4.7    Effects on ability to drive and use machines

Velphoro has no or negligible influence on the ability to drive and use machines.